Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Laube

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Cells|February 25, 2022
CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma CellsCathleen Haase-Kohn, Markus Laube, Cornelius K Donat, et al.
Pharmaceutics|July 30, 2025
PET and SPECT Tracer Development via Copper-Mediated Radiohalogenation of Divergent and Stable Aryl-Boronic EstersAustin Craig, Frederik J Sachse, Markus Laube, et al.
Pharmaceutics|May 10, 2020
Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery ApproachesRebecca Rothe, Sandra Hauser, Christin Neuber, et al.
International Journal of Molecular Sciences|March 27, 2025
Exploring a Nitric Oxide-Releasing Celecoxib Derivative as a Potential Modulator of Bone Healing: Insights from Ex Vivo and In Vivo Imaging ExperimentsChristin Neuber, Luisa Niedenzu, Sabine Schulze, et al.
Biochemical and Biophysical Research Communications|November 14, 2012
Visualization of cyclooxygenase-2 using a 2,3-diarylsubstituted indole-based inhibitor and confocal laser induced cryofluorescence microscopy at 20K in melanoma cells in vitroChristoph Tondera, Markus Laube, Christin Wimmer, et al.
Biotechnology Journal|March 21, 2023
Shell engineering in soft alginate-based capsules for culturing liver spheroidsXuan Peng, Željko Janićijević, Sandy Lemm, et al.
Cells|August 12, 2022
Investigation of Radiotracer Metabolic Stability In Vitro with CYP-Overexpressing Hepatoma Cell LinesSandy Lemm, Susanne Köhler, Robert Wodtke, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging AgentsThines Kanagasundaram, Markus Laube, Johanna Wodtke, et al.
Cancers|October 16, 2024
Combined PET Radiotracer Approach Reveals Insights into Stromal Cell-Induced Metabolic Changes in Pancreatic Cancer In Vitro and In VivoAlina Doctor, Markus Laube, Sebastian Meister, et al.
Bioorganic & Medicinal Chemistry|May 8, 2012
Radiosynthesis of a ¹⁸F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivoTorsten Kniess, Markus Laube, Ralf Bergmann, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Cells|February 25, 2022
CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma CellsCathleen Haase-Kohn, Markus Laube, Cornelius K Donat, et al.
Pharmaceutics|July 30, 2025
PET and SPECT Tracer Development via Copper-Mediated Radiohalogenation of Divergent and Stable Aryl-Boronic EstersAustin Craig, Frederik J Sachse, Markus Laube, et al.
Pharmaceutics|May 10, 2020
Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery ApproachesRebecca Rothe, Sandra Hauser, Christin Neuber, et al.
International Journal of Molecular Sciences|March 27, 2025
Exploring a Nitric Oxide-Releasing Celecoxib Derivative as a Potential Modulator of Bone Healing: Insights from Ex Vivo and In Vivo Imaging ExperimentsChristin Neuber, Luisa Niedenzu, Sabine Schulze, et al.
Biochemical and Biophysical Research Communications|November 14, 2012
Visualization of cyclooxygenase-2 using a 2,3-diarylsubstituted indole-based inhibitor and confocal laser induced cryofluorescence microscopy at 20K in melanoma cells in vitroChristoph Tondera, Markus Laube, Christin Wimmer, et al.
Biotechnology Journal|March 21, 2023
Shell engineering in soft alginate-based capsules for culturing liver spheroidsXuan Peng, Željko Janićijević, Sandy Lemm, et al.
Cells|August 12, 2022
Investigation of Radiotracer Metabolic Stability In Vitro with CYP-Overexpressing Hepatoma Cell LinesSandy Lemm, Susanne Köhler, Robert Wodtke, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging AgentsThines Kanagasundaram, Markus Laube, Johanna Wodtke, et al.
Cancers|October 16, 2024
Combined PET Radiotracer Approach Reveals Insights into Stromal Cell-Induced Metabolic Changes in Pancreatic Cancer In Vitro and In VivoAlina Doctor, Markus Laube, Sebastian Meister, et al.
Bioorganic & Medicinal Chemistry|May 8, 2012
Radiosynthesis of a ¹⁸F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivoTorsten Kniess, Markus Laube, Ralf Bergmann, et al.
Pageof 6